difelikefalin
- Business Wire
VFMCRP and Cara Therapeutics announce European Medicines Agency has accepted to review the Marketing Authorization Application for difelikefalin
Companies have successfully submitted the EU regulatory application for marketing authorization for difelikefalin If approved, difelikefalin injection will be the…
Read More » -
Vifor Pharma and Cara Therapeutics sign US license agreement for i.v. Korsuva™* to treat dialysis patients with pruritus
St. Gallen, Switzerland & Stamford, Conn., United States: Vifor Pharma secures US commercial rights for i.v. Korsuva in non-Fresenius Medical…
Read More »